Nanoform
Business Services · Finland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Viikinkaari Cultivator Ii 4, Helsinki, U...Phone Number
+358 293700150Website
www.nanoform.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nanoform
Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform's platform technologies. The company focuses on reducing clinical attrition and on enhancing drug molecules' performance through its nanoforming technologies and formulation services. Nanoform's capabilities include GMP manufacturing, and its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications. Nanoform's shares are listed on the Premier-segment of Nasdaq First North Growth Market in Helsinki (ticker: NANOFH) and Stockholm (ticker: NANOFS). Certified Adviser: Danske Bank A/S, Finland Branch, +358 40 744 1900.Explore more
Nanoform Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nanoform your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Nanoform
Earning: See what the market has to say on Nanoform recently announced quarterly report
Check out if Nanoform is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Nanoform had a recent Job posting/layoffs
Product Launch: Get notified when Nanoform launches new products
Nanoform, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Nanoform has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Nanoform has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Nanoform is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nanoform is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nanoform.
Nanoform Tech Stack
A closer look at the technologies used by Nanoform
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Person-Based
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Nanoform News & Media
Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc
Company release Nanoform Finland Plc April 15, 2025 14.10 Finnish time / 13.10 SwedishNanoform Finland Plc – Manager’s Transactions – Peter Hänninen
Company release Nanoform Finland Plc November 19, 2024 20.45 Finnish time / 19.45 Swedish time Nanoform Finland Plc – Manager’s Transactions – Peter Hänninen Helsinki, Finland – Manager’s transaction related to Nanoform Finland Plc’s General Counsel and Chief Development Officer Peter Hänninen’s purchase of Nanoform Finland Plc shares: Nanoform Finland Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Peter Hänninen PosNanoform Finland Plc – Manager’s Transactions – Albert Hæggström
Company release Nanoform Finland Plc November 19, 2024 20.45 Finnish time / 19.45 Swedish time Nanoform Finland Plc – Manager’s Transactions – Albert Hæggström Helsinki, Finland – Manager’s transaction related to Nanoform Finland Plc’s Member of the Board and CFO Albert Hæggström’s purchase of Nanoform Finland Plc shares: Nanoform Finland Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Albert Haeggström Position: MembNanoform Q3 2024 report: Record number of new projects signed
Company Announcement Nanoform Finland Plc November 18, 2024 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Nanoform Q3 2024 report: Record number of new projects signed A record number of new non-GMP projects signed in the quarter, helped by a significantly increased interest in our Biologics offering. Revenue growth is back and is expected to accelerate in coming quarters and years. Most GMP Quality Control analytical activities insourced after receiving Fimea license in August.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Nanoform
Sign Up For FreeTo access detailed company insights
Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform's platform technologies. The company focuses on reducing clinical attrition and on enhancing drug molecules' performance through... Read More
